Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System

Letter Oncology

Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic

Ziad Bakouny et al.

Summary: This cohort study examines the number of patients receiving cancer screening tests and subsequent cancer diagnoses in one healthcare system in the northeastern United States during the COVID-19 pandemic.

JAMA ONCOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States

A. DeGroff et al.

Summary: Women from racial and ethnic minority groups in the United States face a disproportionate burden of cervical and breast cancers, with the COVID-19 pandemic exacerbating these disparities by reducing screening services. The NBCCEDP, which provides cancer screening services to low-income and uninsured women, saw a significant decline in breast and cervical cancer screening tests in April 2020 compared to previous years. While screening volumes began to recover in the following months, they still remained below the 5-year averages, particularly in rural areas.

PREVENTIVE MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Cancer screening in the US through the COVID-19 pandemic, recovery, and beyond

Jennifer M. Croswell et al.

Summary: The disruption caused by COVID-19 to cancer screening has highlighted the need to prioritize those who have never been screened or are significantly out of date with screenings. This challenging period could also be an opportunity to reassess early detection programs towards a more explicit, thoughtful, and just prioritization for populations historically experiencing cancer disparities. By careful planning and focusing on populations with the most to gain, we can positively impact cancer outcomes for all in the future.

PREVENTIVE MEDICINE (2021)

Add to Collection

Article Oncology

Reduction in Standard Cancer Screening in 2020 throughout the US

Leslie K. Dennis et al.

Summary: The COVID-19 pandemic had a significant impact on cancer screening in the United States, with noticeable decreases in screening percentages among racial minority groups. The importance of cancer screening was underscored, and it is expected that the 2021 data will show even greater decreases.

CANCERS (2021)

Add to Collection

Review Microbiology

A Review of the Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: Implications and Solutions

Suneha Sundaram et al.

Summary: The COVID-19 pandemic has significantly reduced colorectal cancer screening rates, leading to missed diagnoses at early stages and increasing difficulty in treatment. As endoscopy units return to normal practices, a backlog of cases remains to be dealt with, necessitating appropriate strategies.

PATHOGENS (2021)

Add to Collection

Article Oncology

Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic

Ronald C. Chen et al.

Summary: The COVID-19 pandemic led to significant declines in cancer screening rates, resulting in an estimated deficit of 9.4 million screenings across the US population in 2020. These declines varied by geographic region and socioeconomic status index, with the use of telehealth associated with higher screening rates. Public health efforts are needed to address this large deficit in cancer screening associated with the pandemic.

JAMA ONCOLOGY (2021)

Add to Collection

Letter Oncology